Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...

Amgen (AMGN) reported today the highly anticipated results of a mid-stage trial of its experimental weight loss drug and ...

Consider, for example, that a study by Hartford Funds and Ned Davis Research found that between 1973 and 2023, companies that ...

Pfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of this ...

Truqap’s positive clinical data comes after it failed a late-stage study in metastatic triple-negative breast cancer. It ...

Investors looking for a way to pump up their passive income streams want to turn their attention toward the pharmaceutical ...

Australia's national drug regulator, the Therapeutic Goods Administration (TGA), approved Pfizer's newest vaccine in October.

New research led by the University of Washington found that wildfire smoke is especially hazardous to people's memory health. An analysis of the health care records of 1.2 million Southern California ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Pfizer (PFE – Research Report), with a price target ...

Acoramidis becomes the second drug ever approved for this condition, based on the results of the ATTRibute-CM trial.

Anthropic is embroiled in a copyright lawsuit alleging its Claude chatbot regurgitates copyrighted, sometimes without being ...

In this Q&A, He discussed Boehringer's investments in AI as well as areas where the technology could deliver greater value for pharma.